Recent changes to opioid medications, from 1 June 

The Therapeutic Goods Administration is implementing a number of regulatory changes in order to minimise the harms caused by opioid prescription medicines to Australians each year, and we've put together important information to keep you up-to-date
Spotlight on: Scleroderma 

Scleroderma - also called 'systemic sclerosis' - is an autoimmune condition, which affects the connective tissues of the body (tissues that hold together joints, muscles, blood vessels and internal organs). Many different areas of the body can be affected, such as the lungs, heart, kidneys, oesophagus & gastrointestinal tract - keep reading.

Changes to getting modified release paracetamol

From 1 June, consumers will be required to speak to a pharmacist before purchasing modified release paracetamol products, but are not required to have a prescription from a doctor. These changes will not affect the wide range of immediate release paracetamol products that are available on the market - read more.

Exclusive offer from Adjusta Mattress 

Our newest Arthritis Australia Supporter, Adjusta Mattress, is offering our newsletter subscribers up to 25% off of all Sleep Systems. Just mention code: ARTHAUS1

Your donation is tax deductible! Donate to our National Research Program today!
Contacting Us
We want our community to feel safe and informed during these difficult times. If you feel uncertain about any of the information you are receiving or would like to ask any questions, please contact the friendly team on the National Arthritis Infoline.

National Arthritis Infoline: 1800 011 041
Arthritis Australia website:
Arthritis Australia email:
Copyright © 2020, Arthritis Australia, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.